Ypsomed

In News

Ypsomed carves out diabetes business in $512M deal to focus on GLP-1 self-injectors - Fierce Biotech

Fierce Biotech - Apr 23, 2025

Ypsomed brings autoinjector for dual GCG/GLP-1 delivery to China - drugdeliverybusiness.com

drugdeliverybusiness.com - Jul 01, 2025

Is Ypsomed Holding AG's (VTX:YPSN) Stock's Recent Performance Being Led By Its Attractive Financial Prospects? - Yahoo Finance

Yahoo Finance - Jun 23, 2025

Medtech manufacturer Ypsomed opens first production facility in China - BioSpectrum Asia

BioSpectrum Asia - Jul 03, 2025

Ypsomed and Sidekick Health launch a collaborative digital health solution for obesity management - PR Newswire

PR Newswire - Apr 07, 2025

BD and Ypsomed Collaborate to Advance Self-Injection Systems for High Viscosity Biologics - BD Newsroom

BD Newsroom - Oct 23, 2024

Ypsomed will make injection pens for Novo Nordisk's CagriSema, source says - Reuters

Reuters - Nov 22, 2024

One of Medtech's Top 100 Companies Is Moving Away from the Diabetes Space - Medical Device and Diagnostic industry

Medical Device and Diagnostic industry - Apr 22, 2025

Ypsomed pivots with CHF 420 million diabetes unit sale to TecMed - Greater Geneva Bern area

Greater Geneva Bern area - Apr 23, 2025

Ypsomed to sell diabetes business, insulin delivery tech to TecMed for $517.7M - MassDevice

MassDevice - Apr 22, 2025

Ypsomed to Sell Diabetes Care Biz to TecMed for $517M - Medical Product Outsourcing

Medical Product Outsourcing - Apr 22, 2025

Is Ypsomed Holding AG's (VTX:YPSN) Stock's Recent Performance Being Led By Its Attractive Financial Prospects? - simplywall.st

simplywall.st - Jun 27, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.